$Nasdaq Composite Index (.IXIC.US)$let me first start off saying this is not my idea I saw it on TV and I know people do follow these companies and it makes all the logical sense in the world. if Harris wins she has says that she wants to legalize pot okay that's one of the things that she has flip-flopped on because when she was prosecutor she put hundreds of people in jail for possession of pot. now she believes that it should be legal so if Harris wins here's three companies that you may wan...
$Veru Inc (VERU.US)$ Veru Announces Meta-analysis of Body Composition Data from Older Patients with Obesity which Supports Potential for Enobosarm to Optimize Weight Loss at ObesityWeek Veru Inc. presented a meta-analysis of enobosarm's effects on body composition in older obese patients at ObesityWeek 2024. The analysis, based on four previous clinical trials, showed that enobosarm 3mg treatment led to better outcomes compared to placebo. By Day 147, enobosarm-treated subjects showed greater...
Just sold 50% of my holdings of CGC as it is reaching its resistance at 5.8. If it can go higher than 6.15 then it should go up to 8. Just take 50% profits for now.
$Tilray Brands (TLRY.US)$if Tilray isn't careful they are going to end up bankrupting theirself over their own greediness.its happen to other companies and they aren't immune.They should learn to leave well enough alone.
2
1
Report
BullRunner
:
That’s not going to happen. They have to many assets and whales are piling in on $3 calls.
if Harris wins she has says that she wants to legalize pot okay that's one of the things that she has flip-flopped on because when she was prosecutor she put hundreds of people in jail for possession of pot. now she believes that it should be legal so if Harris wins here's three companies that you may wan...
Veru Announces Meta-analysis of Body Composition Data from Older Patients with Obesity which Supports Potential for Enobosarm to Optimize Weight Loss at ObesityWeek
Veru Inc. presented a meta-analysis of enobosarm's effects on body composition in older obese patients at ObesityWeek 2024. The analysis, based on four previous clinical trials, showed that enobosarm 3mg treatment led to better outcomes compared to placebo. By Day 147, enobosarm-treated subjects showed greater...
They make the ADD meds, which is in short supply, still.
No comment yet